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Abstract - Recently public’s attention to the importance of 
healthy food increases rapidly. Probiotic based food 
exploiting lactic acid bacteria is among the healthy food. 
Lactobacillus plantarum JR64 isolate from Morinda citrifolia 
fruit was assessed for its probiotic in-vivo by using Wistar  
Rat. The purpose of this research was to study the ability of 
probiotic Lactobacillus plantarum JR64 in lowering serum 
LDL (Low Density Lipoprotein) of Wistar Rat. Twenty Rats 
were grouped into 4, each group consisted of 5 Rats. First 
Group was a negative control  given standard normal diet of 
20 gr/day plus aquadest. Second Grup was a positive control 
given cholesterol normal diet 20 gr /day plus Propil Tio Urasil 
(PTU) 60 mg/kg body weight/day. Third Group was 
supplemented with normal diet 20 gr /day plus Propil Tio 
Urasil (PTU) 60 mg  kg body weight /day and  1012 CFU 
Lactobacillus plantarum JR64. Fourth Group was the same 
as third Group unless the probiotic using commercial 
probiotic Lactobacillus bulgariccus at 1012 CFU. Blood 
samples were withdrawn for measurement of total 
cholesterol, triglyceride, High Density Lipoprotein (HDL), 
and Low Density Lipoprotein (LDL) cholesterol every week 
and measured by using spectrophotometer with 546 
nanometers wavelength. The results show that probiotic 
Lactobacillus plantarum JR64 isolated from noni juice 
significantly (p < 0,01) reduce Low Density Lipoprotein 
(LDL) and Triglyceride in vivo  and tend to reduce High 
Density Lipoprotein (HDL) and total cholesterol.  
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I. INTRODUCTION 
 
Recently, public attention to the importance of healthy 
foods increases along with the growing of knowledge 
society. In addition, the increasing of the community 
lifestyle contributes to people's demands for healthy foods. 
One type of healthy food products that growing rapidly is  
probiotic products.  
Group of lactic acid bacteria (LAB) is one of the 
widely used probiotic cultures.  Most of LAB is not 
pathogenic; some strains have acquired the status Gras 
(Generally Recognized as Safe) from the FDA. LAB able 
to grow in the path of intestine and can suppress the 
growth of pathogenic enteric bacteria.  These 
characteristics are utilized to maintain a healthy body and 
considered LAB used as probiotics (Ray, 1996; Gilliland, 
1989). However, not all probiotics are lactic acid bacteria. 
Probiotics are living microorganisms that have beneficial 
health effects by improving host intestinal micro flora 
balance. 
LAB as probiotics needs requirements, namely 
permanent microorganisms of the human digestive track. 
grow and survive on the food before consumption, survive 
even though through the digestive tract, resistant to 
stomach acid, resistant to some antibiotics, resistant to 
lisosym, grown in the intestine and have attachment ability 
to the human intestinal cell ephitel, beneficial effects on 
the intestine, produce acid fast and in large quantity, 
capable to produce anti-microbial components other than 
acid (bacteriocin, diacetyl) that effectively inhibit other 
undesirable bacteria especially pathogen bacterial 
(Havenaar and Jos, 1992; Daeschel, 1989). 
 Control of diseases in humans and cattle by probiotic 
activity has been done for centuries. Probiotics are foods 
containing living microorganisms that actively promote 
health. This is achieved by correcting the balance of 
intestinal flora if taken alive and in adequate amounts. 
According to Fuller (1987), in common there are three 
working models of probiotics are: (1) reduce microbial 
populations through competition by producing 
antimicrobial compounds or through competition of 
nutrients and where sticking to the wall intestinal; (2) alter 
microbial metabolism by increasing or lower enzyme 
activity and (3) stimulate immunity by increasing antibody 
levels or activity of macrophages, while the effectiveness 
of probiotics is determined by its ability to provide 
healthful effect, nature is not pathogenic, non toxic and 
also because of its ability to survive and metabolic activity 
in the intestine. Lactic acid bacteria can        also lower 
cholesterol by inhibiting the activity of enzyme 3-hydroxy-
3-coenzyme A reductase metilglutaril (HMG CoA 
reductase), cholesterol degradation to de-conjugated 
compounds of co-prostanol and bile salts. 
The objective of this study was to test the potential as 
probiotic agents that lowering cholesterol levels and 
lipoprotein profiles of Lactobacillus plantarum JR64 strain 
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by using mice as test animals. Lactobacillus plantarum 
JR64 strain was isolated from microbes in the beverage 
badeg pace. Badeg pace is a traditional drink that similar 
to noni juice (Morinda citrifolia).  Badeg pace is 
fermented spontaneously and it has health properties. 
Badeg pace has become the beverage of Ponorogo from 
generation to generation that believed to provide health 
effects. One strain of lactic acid bacteria isolated from 
these beverages is Lactobacillus plantarum JR64. 
However, growth in media of noni fruit juice has not been 
able to achieve an effective concentration as probiotics. 
Limited growth problem of Lactobacillus plantarum 
JR64 in origin, media, namely noni juice, so it can not 
achieve effective concentrations as probiotic agents.  This 
problem can be overcome through the substitution of 
growth medium containing sufficient nutrients for growth. 
Media formulations have been conducted using corn milk 
was able to support the nutritional needs during the 
formation of biomass and metabolites are expected. 
As the benefits of lactic acid bacteria in general as 
mentioned above and with the discovery of Lactobacillus 
plantarum JR64 isolates that are expected as a candidate 
probiotic, then need to be tested in-vitro and in-vivo. In-
vivo testing will be conducted using test animals such as 
white mice. Rats are mammals that have a significant role 
in human life, whether beneficial or harmful. 
Advantageous properties especially in terms of its use as a 
laboratory animal, such as rats (Rattus norvegicus albino 
strain). Rats as omnivorous animals, can consume all types 
of food consumed by humans, both derived from animals 
and plants. Therefore, rats are assumed to have similar 
digestive tract and metabolic processes with humans. 
 
II. MATERIALS AND METHODS 
 
Twenty Rats were grouped into  4, each group 
consisted of 5 Rats. First group was a negative control  
given standard normal diet of 20 gr/day plus aquadest. 
Second grup was a positive control given cholesterol 
normal diet 20 gr /day plus Propil Tio Urasil (PTU) 60 
mg/kg body weight/day.  Third group was supplemented 
with normal diet 20 gr /day plus Propil Tio Urasil (PTU) 
60 mg  kg body weight /day and  1012  Cfu Lactobacillus 
plantarum JR64. Fourth group was the same as third group 
unless the probiotic using commercial probiotic 
Lactobacillus bulgariccus at 1012  Cfu (FNCC41, UGM),.  
Blood samples were withdrawn for measurement of 
total cholesterol, triglyceride, High Density Lipoprotein 
(HDL), and Low Density Lipoprotein (LDL) cholesterol 
every week and measured by using spectrophotometer with 
546 nanometers wavelength. Before blood samples 
witdrawn, rats must free from food and drink more less 16 
hours. Blood samples take with hematokrit  and fill in 
eppendorf tube contained EDTA and serum was obtained 
by centrifugation at 10.000 rpm for  5 min.   Total 
cholesterol was measured using CHODP-PAP method 
(Cholesterol Oxydase Phenol Amino Phenazon) and 
tryglyserida with GPO method (Glycerol-3-phosphate-
oxydase). 
III. RESULTS AND DISCUSSION 
 
Feed intake and changes in condition rats 
This study used male white Wistar rats with body 
weights ranging from ± 200-250 gr. White rats fed for six 
weeks, including one-week adaptation period and 5 weeks 
of treatment. The observation on the development of rat's 
body weight during the change took place, it is estimated 
that a normal body weight of animals would increase in 
line with age. Increased body weight is influenced by 
dietary factors. Diets with high fat and cholesterol content 
causing an increase in body weight faster than diet with 
low fat content. Besides the existence of abnormalities in 
metabolism may also affect body weight. 
Figure 1 showed that all groups decreased body 
weight after receiving treatment. This was caused by 
factors that are influenced by stress hormones cortisol and 
adrenaline. Adrenaline causes your fat burning while 
cortisol increased supply of glucose to burning and energy 
formation. Besides giving propyl tiourasil every day can 
increase body weight reduction. Propyl tiourasil can affect 
the adrenal cortex in changing the cholesterol into cortisol 
(Murray, et. al., 2003).  
 
 
Figure 1. Decreased body weight after receiving treatment.           
Symbol : ● : Negative control,  ■ :  Positive control,  ▲: 
Lactobacillus  plantarum JR64    ♦ : Lactobacillus   bulgaricus 
 
Average total amount of feed for rats treated were 
presented in Figure 2. Group A which consume more on 
average 18.5% of the weight of feed given each day as 
many as 20 gr. While for group B, C and D are 
respectively 11.9% , 11.3% and 13.4%. In group B, C and 
D obtain the feed has a relatively high fat content can lead 
to eating time interval becomes longer, so the amount of 
feed consumed during the period of 24 hours will be less. 
The high amount of feed consumed by the group A causes 
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an increase in body weight in these groups was higher than 
group B, C and D. 
 
 
Figure 2. The average of consumption of feed by Wistar rats.                     
Symbol : A : Control Negative,  B :  Control Positive,  C: Lactobacillus  
plantarum JR64   D : Lactobacillus   bulgaricus 
 
Effect of probiotic agents to decrease LDL cholesterol 
Figure 3. showed a relationship between the time of 
consumption of probiotics with the change in the level of 
LDL-Cholesterol (mg / dL). Lipid-containing foods 
undergo a process in such a way before is absorbed by the 
intestine. That process is the cholesterol ester hydrolysed 
to cholesterol in food is mixed with the esterified 
cholesterol and bile cholesterol before absorbed, then this 
compound will be incorporated into the chylomicron. 
Chylomicron will react with lipoprotein lipase to form 
chylomicron remaining, then the remaining chylomicron 
receptor reacts with Low Density Lipoprotein (LDL) 
cholesterol and hydrolyzed into cholesterol. Very Low 
Density Lipoprotein (VLDL are formed in the liver to 
carry cholesterol into the plasma and converted to Low 
Density Lipoprotein (LDL) cholesterol receptors will then 
be taken by the Low Density Lipoprotein (LDL) in the 
liver and ekstrahepatik network. Approximately 75-80% of 
Low Density Lipoprotein (LDL) Cholesterol will be 
converted to High Density Lipoprotein (HDL cholesterol) 
by the enzyme Lecithin Cholesterol Acyl transferase 
Kolesteril (HUW) to be transported to the liver and 
circulated again. (Murray, et. al., 2003). 
Increased cholesterol in rats with propyl tiourasil was 
one way to accelerate the increase in endogenous 
cholesterol by suppressing the formation of receptor, Low 
Density Lipoprotein (LDL) in the liver and can increase 
the activity of enzyme 3-hydroxy-3-metilglutaril coenzyme 
A (HMG Co A). Besides the increase of cholesterol can 
also occur due to absorption of fat in the diet (exogenous) 
and the occurrence of lipolysis in the body (endogenous) 
(Murray  et. al., 2003). 
The results showed that probiotic Lactobacillus 
plantarum JR64 could prevent the increase in total 
cholesterol significantly (P <0.05). It seemed that 
cholesterol reduction has to do with high levels of fat in 
feces. This was according to research conducted Usman 
Pato (1999) which stated that lactic acid bacteria capable 
of lowering blood cholesterol by sticking in the intestinal 
wall, then multiply and perform the role of health benefit 
by producing the enzyme bile salt hidrolase (BSH), which 
resulted in increased acid conjugated bile that is not easily 
absorbed from the small intestine compared with bile acid 
conjugation. Conjugated bile acids by high hence 
decreasing intestinal absorption of fat and fatty deposits to 
be reduced because of fats used for synthesized into bile. 
 
 
 
Figure 3. Effect of probiotic candidate to ability lowering 
Cholesterol (LDL).            Symbol : ● : Negative control,  ■ :  
Positive control,  ▲: Lactobacillus  plantarum   JR64  ♦ : 
Lactobacillus   bulgaricus 
 
In addition Lactobacillus plantarum JR64 that is a 
possibility of lactic acid bacteria strains able to degrade 
cholesterol to co-prostanol namely a sterol that can not be 
absorbed by the intestines, then koprostanol and residual 
cholesterol excreted feces together. 
Another mechanism in lowering cholesterol levels is by the 
formation of propionic acid unsaturated fatty acid 
compound which inhibits the synthesis of cholesterol 
through the inhibition of enzyme activity of 3-hydroxy-3-
metilglutaril coenzyme A (HMG Co A) thus formed no 
mevalonat (Harianto, 1996 and Napitipulu, 2003). 
However, the effect of probiotic Lactobacillus 
plantarum JR64 to decrease triglyceride levels, levels of 
Low Density Lipoprotein (LDL) and increased levels of 
High Density Lipoprotein (HDL) cholesterol were not 
significant (P> 0.05). This occurs because of Lactobacillus 
plantarum are not able to prevent the endogenous synthesis 
of cholesterol in the body for five weeks, so that 
cholesterol carried by lipoproteins in the blood are not 
influenced by probiotics, but directly absorb exogenous 
cholesterol in the intestine and excress it through faces. 
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Effect of probiotic agents on the decrease in total 
cholesterol 
Mayes (1997) suggested that the release of cholesterol 
from the body through several streets of liver cholesterol to 
form bile, released into the intestine and subsequent 
cholesterol along with fecal bile acids is lost, lost in the 
intestinal mucosa and skin, joined the steroid hormones 
and issued joint urine. The measurement results are 
presented in total cholesterol. 
Figure 4 illustrated changes in total cholesterol level 
of each group during the treatment. At the end of 
adaptation (week 0), total cholesterol level for all groups 
under normal conditions (69-81 mg / dl).  Normal 
cholesterol levels from a variety of research rats varies 
according to age, species and type of feed given. In the 
induction phase (weeks 1-4) of total cholesterol in the 
control group is positive, probiotic agents has increased 
except in the negative control groups. Rising levels of 
cholesterol caused by feeding high cholesterol and delivery 
of PTU (propyl Tiourasil). 
From the results of tests, the probiotic group had 
significantly different values (P <0.01) with negative 
control group and has a value not significantly different 
(P> 0.05) with the positive control group. Therefore there 
was no difference with the positive control groups, 
probiotics did not have a significant effect on decreasing 
blood cholesterol levels. 
 
 
Figure 4. Effect of probiotic candidate to ability lowering 
Cholesterol Total.  Symbol : ● : Negative control,  ■ :  Positive 
control,  ▲: Lactobacillus  plantarum JR64  ♦ : Lactobacillus   
bulgaricus 
 
Effect of probiotic agents to decrease triglyceride levels 
Figure 5 showed that the changes in triglyceride levels 
during treatment. Late adaptation (week 0) triglyceride 
level of all groups under normal conditions (58-86 mg / 
dl). Induction phase (week 1 to week 4) the average 
positive control group, triglyceride levels decreased from 
74.38 mg / dl to 63.34 mg / dl. From the results of further 
tests showed that probiotic agents is not significant (P> 
0.05) with negative control group but were highly 
significant (P <0.01) toward a positive control. This 
indicates that the agents can lower triglyceride levels 
probiotics at the same level or near-normal cholesterol 
levels. 
 
 
Figure 5. Effect of probiotic candidate to ability lowering 
Triglycerides.    Symbol : ● : Negative control,  ■ :  Positive 
control,  ▲: Lactobacillus  plantarum JR64   ♦ : Lactobacillus   
bulgaricus 
 
IV. CONCLUSION 
Probiotic Lactobacillus plantarum JR64 isolated from 
noni juice significantly (p < 0,01) reduce Low Density 
Lipoprotein (LDL) and Triglyceride in vivo  and tend to 
reduce High Density Lipoprotein (HDL) and total 
cholesterol. 
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